The leading reference for the diagnosis and management of fluid,
electrolyte, and acid-base imbalances in small animals, Fluid,
Electrolyte, and Acid-Base Disorders in Small Animal Practice, 4th
Edition provides cutting-edge, evidence-based guidelines to enhance
your care of dogs and cats. Information is easy to find and easy to
use, with comprehensive coverage including fluid and electrolyte
physiology and pathophysiology and their clinical applications, as
well as the newest advances in fluid therapy and a discussion of a
new class of drugs called vaptans. Lead author Stephen DiBartola is
a well-known speaker and the "go-to" expert in this field, and his
team of contributors represents the most authoritative and
respected clinicians and academicians in veterinary medicine. Over
30 expert contributors represent the "cream of the crop" in small
animal medicine, ensuring that this edition provides the most
authoritative and evidence-based guidelines. Scientific,
evidence-based insights and advances integrate basic physiological
principles into practice, covering patient evaluation, differential
diagnosis, normal and abnormal clinical features and laboratory
test results, approaches to therapy, technical aspects of therapy,
patient monitoring, assessing risk, and prediction of outcomes for
each disorder. Hundreds of tables, algorithms, and schematic
drawings demonstrate the best approaches to diagnosis and
treatment, highlighting the most important points in an easy-access
format. Drug and dosage recommendations are included with treatment
approaches in the Electrolyte Disorders section. Clear formulas in
the Fluid Therapy section make it easier to determine the state of
dehydration, fluid choice, and administration rate and volume in
both healthy and diseased patients. Updated chapters cover the
latest advances in fluid therapy in patient management, helping you
understand and manage a wide range of potentially life-threatening
metabolic disturbances. Expanded Disorders of Sodium and Water
chapter includes information on a new class of drugs called
vaptans, vasopressin receptor antagonists that may soon improve the
ability to manage patients with chronic hyponatremia. Hundreds of
new references cover the most up-to-date advances in fluid therapy,
including renal failure and shock syndromes.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!